Table II.

General and clinical information of study subjects

Healthy ControlsMeasles Patients
Gender
 Male52% (13/25)50% (20/40)
 Female48% (12/25)50% (20/40)
Age
 Median3635
 Range20–6118–62
Day of sample collection post-rash onset
 Median4.5
 Range0–20
Clinical symptoms
 Koplik spot70% (28/40)
 Coryza87.5% (35/40)
 Conjunctivitis77.5% (31/40)
 Bronchitis/pneumonia57.5% (23/40)
 Vomit/diarrhea57.5% (23/40)
 Liver dysfunction20% (8/40)